Relative efficacy of ondansetron,granisetron,dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy
Restricted accessEditorialFirst published online June, 2006
Relative efficacy of ondansetron,granisetron,dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy
HeskethPJ. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting.Cancer Invest2000; 18: 163–73.
2.
Del FaveroA, RoilaF, TonatoM. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.Drug Saf1993; 9: 410–28.
3.
HeskethP, NavariR, GroteT, GrallaR, HainsworthJ, KrisM, AnthonyL, KhojastehA, TapazoglouE, BenedictC, HahneW. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in the patients with cancer.J Clin Oncol1996; 14: 2242–49.
